Dr Reddys Inks commercialisation Deal with Hatchtech
Dr Reddy’s Laboratories has announced the signing of a commercialisation deal with Hatchtech, an Australian pharmaceutical company for developing an […]
Say something
Tags: Australia, BSE Sensex, Business Partnership, Business/Finance, Canada, Clinical Research, Dr. Reddy's Laboratories, Drug safety, FDA Phase, food and drug administration, Hatchtech, Health/Medical/Pharmaceuticals, India, lice infestation, medicine, New Drug Application, new zealand, Pediculosis capitis, pharmaceutical, Pharmaceutical industry, Pharmaceutical sciences, Pharmacology, prescription head lice product, PROMIUS PHARMA LLC, russia, United States, US Food and Drug Administration, USD, Venezuela, Xeglyze Lotion
Novartis Healthcare Launches Sequadra Inhaler for Advance Treatment of COPD Patients
Novartis Healthcare Private Limited (NHPL) launched Sequadra Inhaler (indacaterol/glycopyrronium) 110mcg/50mcg, a fixed dose combination (FDC) of two bronchodilating active ingredients, […]
Indian Human Embryonic Stem Cell Technology Granted Patent
Indian medical innovation has come to the forefront with the Human Embryonic Stem Cell technology developed by Dr Geeta Shroff […]
Indigenous Test to Monitor Cerebral Palsy Gets Global Recognition
Doctors at Nutech Mediworld have demonstrated the effectiveness of a tool to track improvement of Cerebral Palsy (CP) patients after […]
Allergan to Buy Kythera Biopharmaceuticals for US$ 2.1 Billion
Allergan Plc, a botox-maker, said it has planned to buy Kythera Biopharmaceuticals Inc in a cash-and-stock deal valued at about […]
Nevro Receives FDA Approval for SCS System
Nevro Corp. has announced that it has received approval from the United States Food and Drug Administration (FDA) for its […]
Merck Appoints Udit Batra to Head Combined Life Science Business
Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business […]
Sun Pharma acquires GSK’s opiates business in Australia
Sun Pharmaceutical Industries has acquired multinational drug maker GlaxoSmithKline’s opiates business in Australia. However, the deals of the deal have […]
More salt, worse Kidney
Too much salt in one’s diet increases the risk of contracting kidney problems, says a new research.The researchers found high […]
A Cavity-Free Future
Prof Nigel Pitts, Dental Innovation and Translation Centre, Kings College London Dental Institute in conversation with ENN, discusses the issue […]
Chewing for Health
Michael Kelley, Senior Principal Scientist, Scientific and Regulatory Affairs at Wrigley, in conversation with Shahid Akhter, ENN, talks about the […]
Mylan to acquire Abbott business in $5.3B deal
Mylan Inc announced that it has entered into a definitive agreement with Abbott (NYSE: ABT) whereby Mylan will acquire Abbott’s […]
Link patent drugs pricing to per capita income: Panel
A committee of the Department of Pharmaceuticals (DoPs) has recommended a formula on price negotiation of patented drugs based on this parameter
-
-
Flipkart Health+ App Launched
06-04-2022
